Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.67 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.67 |
| ▸ | CASP1 | P29466 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | SIGMAR1 | Q99720 | 11/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8500856 | 1.00 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL6379725 | 1.00 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL11777969 | 1.00 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL6680538 | 1.00 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL3625544 | 1.00 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL2112457 | 1.00 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL6683681 | 1.00 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL445067 | 0.97 | ALDH1A1 (0.70) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| Iodide SCHEMBL8499688 | 0.95 | ALDH1A1 (0.61) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| Hydrochloric Acid SCHEMBL28408129 | 0.95 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3892371-A1 | FUNCTIONAL STRUCTURE | National University Corporation Hokkaido University (JP) | 2021-10-13 | — | — | EP | disclosed |
| EP-2428501-B1 | DIARYLIODONIUM SALT MIXTURE AND PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF DIARYLIODONIUM COMPOUND | NIPPON CATALYTIC CHEM IND (JP) | 2018-12-12 | — | — | EP | disclosed |
| US-20170166525-A1 | IMIDAMIDE SPHINGOSINE KINASE INHIBITORS | UNIVERSITY OF VIRGINIA | 2017-06-15 | — | — | US | disclosed |
| US-8975203-B2 | Diaryliodonium salt mixture and process for production thereof, and process for production of diaryliodonium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2015-03-10 | — | — | US | disclosed |
| EP-2428501-A1 | DIARYL IODONIUM SALT MIXTURE AND PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF DIARYL IODONIUM COMPOUND | Nippon Shokubai Co., Ltd. (JP) | 2012-03-14 | — | — | EP | disclosed |
| US-20120053048-A1 | Diaryliodonium salt mixture and process for production thereof, and process for production of diaryliodonium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053048-A1 | Diaryliodonium salt mixture and process for production thereof, and process for production of diaryliodonium compound | SPIN4, SALL4, DBF4 | ALDH1A1 4450/4885HPGD 3538/4885ALOX15 3441/4885 |
| US-20170166525-A1 | IMIDAMIDE SPHINGOSINE KINASE INHIBITORS | SPHK2, SPHK1, S1PR2 | ALDH1A1 4570/4885HPGD 1964/4885ALOX15 3422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.